Jing Li, Xuerui Wang, Andreas I. Lackner, Purnima Narasimhan, Lin Li, Vamsee Mallajosyula, Mary M. Johnson, Anna-Lena Höbler, Adam S. Kirosingh, Amy E. Braun, Felistas Nankya, Kenneth Musinguzi, Abel Kakuru, Moses Kamya, Philip J. Rosenthal, Grant Dorsey, Prasanna Jagannathan, Michael Angelo, Jürgen Pollheimer, Stephanie L. Gaw, Virginia D. Winn, Kari C. Nadeau, Mark M. Davis
{"title":"Regulatory KIR + CD8 + T cells are elevated during human pregnancy","authors":"Jing Li, Xuerui Wang, Andreas I. Lackner, Purnima Narasimhan, Lin Li, Vamsee Mallajosyula, Mary M. Johnson, Anna-Lena Höbler, Adam S. Kirosingh, Amy E. Braun, Felistas Nankya, Kenneth Musinguzi, Abel Kakuru, Moses Kamya, Philip J. Rosenthal, Grant Dorsey, Prasanna Jagannathan, Michael Angelo, Jürgen Pollheimer, Stephanie L. Gaw, Virginia D. Winn, Kari C. Nadeau, Mark M. Davis","doi":"10.1126/scitranslmed.adm7697","DOIUrl":null,"url":null,"abstract":"During pregnancy, immune responses must balance protection from infections with tolerance of the semiallogeneic fetus. However, the mechanisms regulating maternal-fetal tolerance remain poorly understood. Recently, we identified CD8 <jats:sup>+</jats:sup> T cells expressing inhibitory killer cell immunoglobulin-like receptors (KIRs) as a regulatory subset important for suppressing self-reactivity in human autoimmune and infectious diseases. To better understand what other roles these cells might play, we asked whether they are active during pregnancy. We first observed an increased frequency of KIR <jats:sup>+</jats:sup> CD8 <jats:sup>+</jats:sup> T cells in the peripheral blood of pregnant people in the second trimester, especially in those carrying a male fetus. In vitro, KIR <jats:sup>+</jats:sup> CD8 <jats:sup>+</jats:sup> T cells inhibited the alloreactive responses of maternal T cells against irradiated cord blood cells and selectively suppressed CD8 <jats:sup>+</jats:sup> T cells targeting male-specific proteins in mothers with male pregnancies. Therefore, the higher induction of KIR <jats:sup>+</jats:sup> CD8 <jats:sup>+</jats:sup> T cells in mothers carrying a male fetus may help suppress additional allogeneic responses triggered by male-specific alloantigens. Longitudinal analysis showed that KIR <jats:sup>+</jats:sup> CD8 <jats:sup>+</jats:sup> T cells undergo expansion and differentiate into functional cytotoxic cells during pregnancy. Single-cell RNA sequencing of decidual CD8 <jats:sup>+</jats:sup> T cells from early pregnancy revealed elevated numbers and increased expression of activation markers in KIR <jats:sup>+</jats:sup> CD8 <jats:sup>+</jats:sup> T cells at the maternal-fetal interface. In addition, a higher frequency of KIR <jats:sup>+</jats:sup> CD8 <jats:sup>+</jats:sup> T cells was associated with spontaneous abortion and preeclampsia. Together, our findings suggest that KIR <jats:sup>+</jats:sup> CD8 <jats:sup>+</jats:sup> T cells may contribute to maternal tolerance by modulating fetal-specific alloreactive T cell responses. They may also be useful as candidate biomarkers or therapeutic targets for human pregnancy disorders.","PeriodicalId":21580,"journal":{"name":"Science Translational Medicine","volume":"27 1","pages":""},"PeriodicalIF":14.6000,"publicationDate":"2025-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Science Translational Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1126/scitranslmed.adm7697","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
During pregnancy, immune responses must balance protection from infections with tolerance of the semiallogeneic fetus. However, the mechanisms regulating maternal-fetal tolerance remain poorly understood. Recently, we identified CD8 + T cells expressing inhibitory killer cell immunoglobulin-like receptors (KIRs) as a regulatory subset important for suppressing self-reactivity in human autoimmune and infectious diseases. To better understand what other roles these cells might play, we asked whether they are active during pregnancy. We first observed an increased frequency of KIR + CD8 + T cells in the peripheral blood of pregnant people in the second trimester, especially in those carrying a male fetus. In vitro, KIR + CD8 + T cells inhibited the alloreactive responses of maternal T cells against irradiated cord blood cells and selectively suppressed CD8 + T cells targeting male-specific proteins in mothers with male pregnancies. Therefore, the higher induction of KIR + CD8 + T cells in mothers carrying a male fetus may help suppress additional allogeneic responses triggered by male-specific alloantigens. Longitudinal analysis showed that KIR + CD8 + T cells undergo expansion and differentiate into functional cytotoxic cells during pregnancy. Single-cell RNA sequencing of decidual CD8 + T cells from early pregnancy revealed elevated numbers and increased expression of activation markers in KIR + CD8 + T cells at the maternal-fetal interface. In addition, a higher frequency of KIR + CD8 + T cells was associated with spontaneous abortion and preeclampsia. Together, our findings suggest that KIR + CD8 + T cells may contribute to maternal tolerance by modulating fetal-specific alloreactive T cell responses. They may also be useful as candidate biomarkers or therapeutic targets for human pregnancy disorders.
期刊介绍:
Science Translational Medicine is an online journal that focuses on publishing research at the intersection of science, engineering, and medicine. The goal of the journal is to promote human health by providing a platform for researchers from various disciplines to communicate their latest advancements in biomedical, translational, and clinical research.
The journal aims to address the slow translation of scientific knowledge into effective treatments and health measures. It publishes articles that fill the knowledge gaps between preclinical research and medical applications, with a focus on accelerating the translation of knowledge into new ways of preventing, diagnosing, and treating human diseases.
The scope of Science Translational Medicine includes various areas such as cardiovascular disease, immunology/vaccines, metabolism/diabetes/obesity, neuroscience/neurology/psychiatry, cancer, infectious diseases, policy, behavior, bioengineering, chemical genomics/drug discovery, imaging, applied physical sciences, medical nanotechnology, drug delivery, biomarkers, gene therapy/regenerative medicine, toxicology and pharmacokinetics, data mining, cell culture, animal and human studies, medical informatics, and other interdisciplinary approaches to medicine.
The target audience of the journal includes researchers and management in academia, government, and the biotechnology and pharmaceutical industries. It is also relevant to physician scientists, regulators, policy makers, investors, business developers, and funding agencies.